
Sign up to save your podcasts
Or
In this week's episode, we’ll learn more about how measurable residual disease might help guide decisions about post-transplant gilteritinib maintenance in FLT3-ITD acute myeloid leukemia, or AML; how stemness contributes to chemotherapy resistance in AML; and effects of babesiosis on red blood cells from individuals with sickle cell disease, sickle cell trait, and wild-type hemoglobin.
Featured Articles:
4.1
4848 ratings
In this week's episode, we’ll learn more about how measurable residual disease might help guide decisions about post-transplant gilteritinib maintenance in FLT3-ITD acute myeloid leukemia, or AML; how stemness contributes to chemotherapy resistance in AML; and effects of babesiosis on red blood cells from individuals with sickle cell disease, sickle cell trait, and wild-type hemoglobin.
Featured Articles:
129 Listeners
72 Listeners
318 Listeners
26 Listeners
487 Listeners
270 Listeners
2 Listeners
184 Listeners
362 Listeners
3 Listeners
2 Listeners
29 Listeners
166 Listeners
48 Listeners
1 Listeners